{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:24:48Z","timestamp":1760909088802},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10147-017-1126-x","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T12:20:36Z","timestamp":1493036436000},"page":"857-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy"],"prefix":"10.1007","volume":"22","author":[{"given":"Teruhisa","family":"Takuwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozo","family":"Kuribayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"issue":"8","key":"1126_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"D Rice","year":"2011","unstructured":"Rice D, Rusch V, Pass H et al. (2011) Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 6(8):1304\u20131312. doi:\n                        10.1097\/JTO.0b013e3182208e3f","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1126_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","volume":"7","author":"L Lang-Lazdunski","year":"2012","unstructured":"Lang-Lazdunski L, Bille A, Lal R et al. (2012) Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 7(4):737\u2013743. doi:\n                        10.1097\/JTO.0b013e31824ab6c5","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1126_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","volume":"83","author":"C Cao","year":"2014","unstructured":"Cao C, Tian D, Park J et al. (2014) A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83(2):240\u2013245. doi:\n                        10.1016\/j.lungcan.2013.11.026","journal-title":"Lung Cancer"},{"issue":"2","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.lungcan.2014.01.021","volume":"84","author":"L Lang-Lazdunski","year":"2014","unstructured":"Lang-Lazdunski L (2014) Surgery for malignant pleural mesothelioma: why, when and what? Lung Cancer 84(2):103\u2013109. doi:\n                        10.1016\/j.lungcan.2014.01.021","journal-title":"Lung Cancer"},{"key":"1126_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.12.009","author":"O Rena","year":"2012","unstructured":"Rena O, Casadio C (2012) Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: an harmful procedure. Lung Cancer. doi:\n                        10.1016\/j.lungcan.2011.12.009","journal-title":"Lung Cancer"},{"issue":"9","key":"1126_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","volume":"27","author":"M Perrot de","year":"2009","unstructured":"de Perrot M, Feld R, Cho BC et al. (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27(9):1413\u20131418. doi:\n                        10.1200\/JCO.2008.17.5604","journal-title":"J Clin Oncol"},{"issue":"10","key":"1126_CR7","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1200\/jco.2006.09.9887","volume":"26","author":"J Jassem","year":"2008","unstructured":"Jassem J, Ramlau R, Santoro A et al. (2008) Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 26(10):1698\u20131704. doi:\n                        10.1200\/jco.2006.09.9887","journal-title":"J Clin Oncol"},{"issue":"2","key":"1126_CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","volume":"63","author":"EH Baldini","year":"1997","unstructured":"Baldini EH, Recht A, Strauss GM et al. (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63(2):334\u2013338","journal-title":"Ann Thorac Surg"},{"key":"1126_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-014-0389-7","author":"S Hasegawa","year":"2014","unstructured":"Hasegawa S (2014) Extrapleural pneumonectomy or pleurectomy\/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. doi:\n                        10.1007\/s11748-014-0389-7","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"8","key":"1126_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D et al. (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12(8):763\u2013772. doi:\n                        10.1016\/s1470-2045(11)70149-8","journal-title":"Lancet Oncol"},{"key":"1126_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-015-0925-1","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa S, Okada M, Tanaka F et al. (2015) Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial). Int J Clin Oncol. doi:\n                        10.1007\/s10147-015-0925-1","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"1126_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","volume":"71","author":"S Bolukbas","year":"2011","unstructured":"Bolukbas S, Manegold C, Eberlein M et al. (2011) Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy. Lung Cancer 71(1):75\u201381. doi:\n                        10.1016\/j.lungcan.2009.08.019","journal-title":"Lung Cancer"},{"issue":"2","key":"1126_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","volume":"8","author":"DR Gomez","year":"2013","unstructured":"Gomez DR, Hong DS, Allen PK et al. (2013) Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol 8(2):238\u2013245. doi:\n                        10.1097\/JTO.0b013e31827740f0","journal-title":"J Thorac Oncol"},{"issue":"14","key":"1126_CR14","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al. (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644. doi:\n                        10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"issue":"6","key":"1126_CR15","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/annonc\/mdi187","volume":"16","author":"C Manegold","year":"2005","unstructured":"Manegold C, Symanowski J, Gatzemeier U et al. (2005) Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 16(6):923\u2013927. doi:\n                        10.1093\/annonc\/mdi187","journal-title":"Ann Oncol"},{"issue":"5","key":"1126_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","volume":"38","author":"VH Gerbaudo","year":"2011","unstructured":"Gerbaudo VH, Mamede M, Trotman-Dickenson B et al. (2011) FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging 38(5):810\u2013821. doi:\n                        10.1007\/s00259-010-1704-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1126_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv398","author":"A Kostron","year":"2015","unstructured":"Kostron A, Friess M, Crameri O et al. (2015) Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesotheliomadagger. Eur J Cardiothorac Surg. doi:\n                        10.1093\/ejcts\/ezv398","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-017-1126-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T17:28:47Z","timestamp":1506014927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-017-1126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s10147-017-1126-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]}}}